---
title: "U.S. stock movement | BioNTech fell over 6%, news reports that Pfizer seeks to sell its stake to cash out over $500 million"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/265754085.md"
description: "Biotechnology company BioNTech (BNTX.US) fell over 6% in early trading, reporting at $104.7. According to sources, Pfizer is seeking to sell its remaining stake in its COVID-19 vaccine partner BioNTech. This equity sale is expected to bring Pfizer up to approximately $508 million in revenue. BioNTech stated that its collaboration with Pfizer remains unchanged and will not comment on any capital market activities of Pfizer"
datetime: "2025-11-13T14:46:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265754085.md)
  - [en](https://longbridge.com/en/news/265754085.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265754085.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/265754085.md) | [繁體中文](https://longbridge.com/zh-HK/news/265754085.md)


# U.S. stock movement | BioNTech fell over 6%, news reports that Pfizer seeks to sell its stake to cash out over $500 million

Biotechnology company BioNTech (BNTX.US) fell over 6% in early trading, reporting $104.7. According to insiders, Pfizer is seeking to sell its remaining stake in its COVID-19 vaccine partner BioNTech. This equity sale is expected to bring Pfizer up to approximately $508 million in revenue. BioNTech stated that its collaboration with Pfizer remains unchanged and will not comment on any capital market activities of Pfizer

### 相关股票

- [BioNTech SE (BNTX.US)](https://longbridge.com/zh-CN/quote/BNTX.US.md)
- [Eli Lilly (LLY.US)](https://longbridge.com/zh-CN/quote/LLY.US.md)
- [Novo Nordisk AS (NVO.US)](https://longbridge.com/zh-CN/quote/NVO.US.md)

## 相关资讯与研究

- [Novo Nordisk A/S Approves Board Changes](https://longbridge.com/zh-CN/news/280694583.md)
- [Novo Nordisk slashes Wegovy prices to court uninsured patients](https://longbridge.com/zh-CN/news/281206892.md)
- [Pfizer and partner BioNTech say they will stop U.S. COVID-19 vaccine study in healthy adults ages 50 to 64 due to slow enrollment](https://longbridge.com/zh-CN/news/281395680.md)
- [EXCLUSIVE-Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles](https://longbridge.com/zh-CN/news/281395077.md)
- [Novo Nordisk's Wegovy Weekly Injection Recommended by UK for Obese Cardiovascular Patients](https://longbridge.com/zh-CN/news/281331550.md)